Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Three new residual error models for population PK/PD analyses

M O Karlsson1, S L Beal, L B Sheiner

  • 1Department of Pharmacy, School of Pharmacy, University of California, San Francisco 94143-0626, USA.

Journal of Pharmacokinetics and Biopharmaceutics
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Handling underlying discrete variables with bivariate mixed hidden Markov models in NONMEM.

Journal of pharmacokinetics and pharmacodynamics·2019
Same author

CORRIGENDUM: Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.

Clinical pharmacology and therapeutics·2018
Same author

Reduced and optimized trial designs for drugs described by a target mediated drug disposition model.

Journal of pharmacokinetics and pharmacodynamics·2018
Same author

Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials.

Journal of clinical pharmacology·2018
Same author

Model averaging for robust assessment of QT prolongation by concentration-response analysis.

Statistics in medicine·2017
Same journal

Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Effect of plasma protein and tissue binding on the time course of drug concentration in plasma.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Pharmacokinetics of methotrexate in solid tumors.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.

Journal of pharmacokinetics and biopharmaceutics·2010
See all related articles

Population pharmacokinetic analyses often overlook complex error structures. This study shows that accounting for serial correlation and time-dependent errors improves parameter estimates, unlike simple assay error models.

Area of Science:

  • Pharmacometrics
  • Statistical modeling
  • Pharmacokinetic analysis

Background:

  • Traditional residual error models in population pharmacokinetics assume error properties similar to assay error.
  • Assay error is often a minor component of the total difference between predicted and observed concentrations.
  • Other error sources with different properties should be considered.

Purpose of the Study:

  • To investigate the impact of complex residual error structures on population pharmacokinetic parameter estimates.
  • To evaluate the performance of different error models, including those accounting for replication, serial correlation, and time-dependent errors.
  • To demonstrate the practical application of these models in real-world pharmacokinetic data analysis.

Main Methods:

Related Experiment Videos

  • Simulation of three complex residual error structures: replication plus assay error, serially correlated errors, and time-dependent error magnitude.
  • Comparison of parameter estimates obtained using traditional models versus models incorporating complex error structures.
  • Application of developed error models to a real pharmacokinetic dataset.

    • Main Results:

    • Ignoring separate replication and assay error sources did not significantly affect parameter estimates.
    • Ignoring serially correlated errors led to biased random-effect parameter estimates; an autocorrelation model improved estimates.
    • Ignoring time-dependent error magnitude caused bias in all population parameter estimates; a two-step time-dependent model improved accuracy.

    Conclusions:

    • Complex residual error structures, particularly serial correlation and time-dependence, significantly impact population pharmacokinetic parameter estimates.
    • Simple models assuming only assay error can lead to biased results.
    • Incorporating appropriate complex error models enhances model building, identifies error sources, and yields more accurate parameter estimates.